Lyondell Chemical Company, Equistar Chemicals, LP and Equistar Funding Corporation Announce Results to Date and Pricing of the C
06 Diciembre 2007 - 9:00AM
PR Newswire (US)
Lyondell Chemical Company Securities: HOUSTON, Dec. 6
/PRNewswire-FirstCall/ -- Lyondell Chemical Company (NYSE:LYO) and
its subsidiaries Equistar Chemicals, LP ("Equistar") and Equistar
Funding Corporation (together with Equistar, the "Equistar
Issuers") announced today that, as of 5 p.m. EST on Dec. 5, 2007
(the "Consent Payment Deadline"), a total of approximately $3.97
billion in aggregate principal amount of the outstanding debt
securities listed in Table 1 below (collectively, the "Notes")
issued by Lyondell or the Equistar Issuers, as applicable, has been
tendered pursuant to the previously announced cash tender offers
(the "Offers") and consent solicitations (the "Consent
Solicitations"). As a result, Lyondell and the Equistar Issuers
have received the required consents from holders to amend each of
the indentures governing the applicable Notes. Upon Lyondell and
the Equistar Issuers accepting for purchase at least a majority in
aggregate principal amount of the applicable Notes outstanding,
each of the supplemental indentures effecting the proposed
amendments as described in the Offer to Purchase and Consent
Solicitation Statement dated Nov. 20, 2007 (the "Offer and Consent
Statement") will become operative. The Offer for each series of
Notes will expire at 12:01 a.m. EST on Dec. 20, 2007, unless
extended or earlier terminated by Lyondell or the Equistar Issuers,
as applicable, in their sole discretion (the "Expiration Date").
Withdrawal rights with respect to the Notes and revocation rights
with respect to corresponding consents have expired. Accordingly,
holders may not withdraw any Notes previously or hereafter
tendered, except as contemplated in the applicable Offers. The
total consideration was determined as of 2 p.m. EST on Dec. 5,
2007. The total consideration per $1,000 principal amount of the
Notes validly tendered at or prior to the Consent Payment Deadline,
not validly withdrawn and accepted for payment (the "Total
Consideration") is set forth in Table 1 below, of which $30 is the
consent payment. The tender offer consideration per $1,000
principal amount of the Notes validly tendered after the Consent
Payment Deadline, not validly withdrawn and accepted for payment
(the "Tender Offer Consideration") equals the Total Consideration
minus the $30 consent payment. In each case, accrued and unpaid
interest on the Notes will be paid in cash from the most recent
interest payment date applicable to the Notes to, but not
including, the applicable payment date for the Offers. The
applicable payment date for Notes tendered on or prior to the
Consent Payment Deadline is expected to be on or about Dec. 20,
2007. The applicable payment date for Notes tendered after the
Consent Payment Deadline and on or prior to the Expiration Date is
expected to be on or about Dec. 21, 2007. Table 1 - Results to Date
and Pricing Information for the Offers Lyondell's Notes Percentage
Tender Tender of Principal CUSIP Security Offer Total Offer Amount
Number Description Yield Consideration Consideration Tendered
10.500% Senior 552078AV9 Secured 3.764% $1,081.17 $1,051.17 99.76%
Notes due 2013 8.000% 552078AW7 Senior Notes 3.429% $1,154.78
$1,124.78 99.67% due 2014 8.250% 552078AX5 Senior Notes 3.601%
$1,197.17 $1,167.17 99.85% due 2016 6.875% 552078AY3 Senior Notes
3.788% $1,155.31 $1,125.31 99.99% due 2017 Equistar Issuers' Notes
Percentage Tender Tender of Principal CUSIP Security Offer Total
Offer Amount Number Description Yield Consideration Consideration
Tendered 10.125% 29444NAF9 Senior Notes 3.857% $1,042.60 $1,012.60
97.96% due 2008 8.750% 29444NAD4 Notes due 3.519% $1,058.51
$1,028.51 97.55% 2009 10.625% 29444NAH5 Senior Notes 3.761%
$1,050.65 $1,020.65 97.95% due 2011 The Offers and Consent
Solicitations are subject to the satisfaction of certain
conditions, including the proposed merger of Lyondell with BIL
Acquisition Holdings Limited, a Delaware corporation and wholly
owned subsidiary of Basell AF S.C.A., a Luxembourg company. The
complete terms and conditions of the Offers and Consent
Solicitations are set forth in the Offer and Consent Statement,
which has been sent to holders of the Notes. Holders are urged to
carefully read the Offer and Consent Statement and related
materials. Goldman, Sachs & Co. and Merrill Lynch & Co. are
the dealer managers for the Offers and solicitation agents for the
Consent Solicitations. Questions regarding the Offers and Consent
Solicitations may be directed to Goldman, Sachs & Co. at (877)
686-5059 (toll-free) or (212) 357-0775 (collect), and Merrill Lynch
& Co. at (888) 654-8637 (toll-free) or (212) 449-4914
(collect). Copies of the Offer and Consent Statement and related
materials may be obtained from the Information Agent, D. F. King
& Co., Inc. at (800) 290-6429 (U.S. toll free) or (212)
269-5550 (Banks and Brokers). This announcement is not an offer to
purchase, a solicitation for acceptance of an offer to purchase, or
a solicitation of consents with respect to, any securities. The
Offers and Consent Solicitations are being made solely pursuant to
the Offer and Consent Statement and related materials. About
Lyondell Lyondell Chemical Company, headquartered in Houston,
Texas, is North America's third-largest independent, publicly
traded chemical company. Lyondell is a leading global manufacturer
of chemicals and plastics, a refiner of heavy, high-sulfur crude
oil and a significant producer of fuel products. Key products
include ethylene, polyethylene, styrene, propylene, propylene
oxide, gasoline, ultra low-sulfur diesel, MTBE and ETBE.
Forward-Looking Statements The statements in this release relating
to matters that are not historical facts are forward-looking
statements. These forward-looking statements are based upon the
current beliefs and expectations of management, and are subject to
significant risks and uncertainties. Actual results could differ
materially based on factors including, but not limited to,
Lyondell's ability to implement its business strategies, including
the ability of Lyondell and Basell to complete the proposed merger;
availability, cost and price volatility of raw materials and
utilities; supply/demand balances; industry production capacities
and operating rates; uncertainties associated with the U.S. and
worldwide economies; legal, tax and environmental proceedings;
cyclical nature of the chemical and refining industries; operating
interruptions; current and potential governmental regulatory
actions; terrorist acts; international political unrest;
competitive products and pricing; technological developments; risks
of doing business outside of the U.S.; access to capital markets;
and other risk factors. Additional factors that could cause results
to differ materially from those described in the forward-looking
statements can be found in the Lyondell, Equistar and Millennium
Annual Reports on Form 10-K for the year ended December 31, 2006
and Quarterly Reports on Form 10-Q for the quarter ended September
30, 2007. DATASOURCE: Lyondell Chemical Company; Equistar
Chemicals, LP CONTACT: media, Susan P. Moore, +1-713-309-4645, or
investors, Douglas J. Pike, +1-713-309-7141, both of Lyondell
Chemical Company Web site: http://www.lyondell.com/
Copyright
Lyondell (NYSE:LYO)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Lyondell (NYSE:LYO)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024